SCHEMBL7609802

SCHEMBL7609802

CCCCNC(=O)[C@H](CC)C[C@H](O)C(Cc1cc(F)cc(F)c1)NC(=O)c1cccc(C(=O)N(CCC)CCC)c1

nearest known ligand 0.88

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.88
BACE2 Q9Y5Z0 18/20 0.88

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4883151 1.00 BACE1 (0.88) BACE1BACE2
SCHEMBL4890158 0.95 BACE1 (0.85) BACE1BACE2
SCHEMBL7609512 0.94 BACE1 (0.84) BACE1BACE2
SCHEMBL4890168 0.94 BACE1 (0.84) BACE1BACE2
SCHEMBL4882945 0.94 BACE1 (1.00) BACE1BACE2
SCHEMBL4882942 0.94 BACE1 (1.00) BACE1BACE2
SCHEMBL4892707 0.93 BACE1 (1.00) BACE1BACE2
SCHEMBL4892714 0.93 BACE1 (1.00) BACE1BACE2
SCHEMBL7607163 0.93 BACE1 (0.84) BACE1BACE2
SCHEMBL4890341 0.93 BACE1 (0.84) BACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1265849-A2 COMPOUNDS AND METHODS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2002-12-18 EP disclosed
WO-2001070672-A2 COMPOUNDS AND METHODS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2001-09-27 WO disclosed